logo
Plus   Neg
Share
Email

Merck Files Six SBLAs To Update Dosing Frequency For KEYTRUDA - Quick Facts

Merck (MRK) said the FDA has accepted for review six supplemental Biologics License Applications (sBLAs) to update the dosing frequency for KEYTRUDA, to include an every-six-weeks dosing schedule option for melanoma and other indications. If approved, KEYTRUDA 400 mg every-six-week dosing option would be available for use in adults in addition to the currently approved dose of 200 mg every-three-week option. The FDA has set a PDUFA date of Feb. 18, 2020.

In the European Union, 400 mg every-six-week dosing for KEYTRUDA monotherapy was approved in March.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Amazon plans to more than double its corporate workforce in Las Vegas by creating 125 additional jobs in the city. The e-commerce giant recently opened a new 30,000 square foot office in Town Square in downtown Las Vegas and plans to expand its corporate workforce in the area to support its Human Resources division. Amazon also said it will donate $100,000 to two food bank partners. Consumer Reports has once again recommended Tesla's Model 3 and Model S sedans as reliable, after the vehicles were previous downgraded by the organization. Consumer Reports said that the two sedans regained its recommendation due to improved reliability reports from owners of the cars, based on the results of its annual Auto Reliability Survey that were announced Thursday. Sears Holdings recalled about 700 units of Kenmore Elite microwave ovens for possible electrical burn hazard, a statement by the U.S. Consumer Product Safety Commission said. The company said the incorrect wiring of the microwave oven causes its exterior to reach temperatures exceeding 183 degrees fahrenheit that could result in a burn hazard to the user.
Follow RTT
>